decoration

Poids de l’Open access dans la production CNRS

Titre
A phase II Bayesian sequential clinical trial in advanced Waldenstrom macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone
BSO - Titre
A phase II Bayesian sequential clinical trial in advanced Waldenstrom macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone
DOI
DOAI
Identifiant WoS
WOS:000406274600014
Accès ouvert
OA - Non
Source - Accès ouvert
OA - Non
Type d'accès
Non OA
Editeur

Informa UK

Source

LEUKEMIA & LYMPHOMA

ISSN
1042-8194
Type de document
  • Article
Notoriété
3 - Correcte
CNRS
Oui
CNRS - Institut
  • INSB - Institut des sciences biologiques
uid:/S2M0H47H
Powered by Lodex 9.6.0
decoration